CoraLite® Plus 488-conjugated DAXX Monoclonal antibody

DAXX Monoclonal Antibody for IF/ICC
Cat No. CL488-67879

产品说明书

CloneNo. 1F3G9

宿主/亚型

Mouse / IgG2b

种属反应性

Human

应用

IF/ICC

BING2, DAP6, DAXX, EAP1, ETS1 associated protein 1, hDaxx

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  CoraLite® Plus 488
规格: 

-/ -


经过测试的应用

Positive IF/ICC detected inA431 cells
Planning an IHC experiment? We recommend our IHCeasy DAXX Ready-To-Use IHC Kit. DAXX primary antibody included.
For other applications, we recommend the unconjugated version of this antibody, 67879-1-Ig

推荐稀释比

应用推荐稀释比
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

CL488-67879 targets DAXX in IF/ICC applications and shows reactivity with Human samples.

经测试应用 IF/ICC Application Description
经测试反应性 Human
免疫原 DAXX fusion protein Ag14606 种属同源性预测
宿主/亚型 Mouse / IgG2b
抗体类别 Monoclonal
产品类型 Antibody
全称 death-domain associated protein
别名 BING2, DAP6, DAXX, EAP1, ETS1 associated protein 1, hDaxx
计算分子量 740 aa, 81 kDa
观测分子量100-130 kDa
GenBank蛋白编号BC109074
基因名称 DAXX
Gene ID (NCBI) 1616
RRIDAB_2934581
偶联类型 CoraLite® Plus 488 Fluorescent Dye
最大激发/发射波长493 nm / 522 nm
形式 Liquid
纯化方式Protein A purification
UNIPROT IDQ9UER7
储存缓冲液 PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3
储存条件Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

Death domain-associated protein (DAXX) is a transcription repressor involved in both physiological and pathological conditions. DAXX overexpression is a common feature in diverse cancers, which correlates with tumorigenesis, disease progression and treatment resistance. Daxx migrated with an apparent molecular weight of approximately 100-130 kDa. (PMID: 31350900, PMID: 32203224, PMID: 31614769)

实验方案

Product Specific Protocols
IF protocol for CL Plus 488 DAXX antibody CL488-67879Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...